| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 35.35 | -0.66 (-1.83%) | 17.25 - 58.91 | 1.1 million (Below Avg) |
Market data as of 2:24PM 05/23/13. Quotes are delayed by at least 15 min.
| Open | 35.70 |
|---|---|
| Previous Close | 36.01 |
| Day's Range | 35.10 - 36.80 |
| Market Cap | 2.1B |
| Avg Volume (10 Day) | 2.3M |
| Price/Earnings (Trailing 12 Mo.) | 11.1x |
| Earnings Per Share (Trailing 12 Mo.) | 3.23 |
| Dividend Yield | 0.25 (2.83%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Pass |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Pass |
| Consistently increased owner earnings? | Pass |
| Sells at 25% discount to intrinsic value? | Pass |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Pass |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
Questcor Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
PR Newswire - Wednesday 05/08/2013 4:01 PM ET
Questcor Reports First Quarter Financial Results
PR Newswire - Tuesday 04/30/2013 4:01 PM ET
| QCOR | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 97.78% | |
| Net Income Growth (1yr) | 625.49% | |
| Total Debt/Equity | 0.09 | |
| LT Debt/Equity | 0.08 | |
| Earnings Yield | 9.01% | |
| Price/Sales | 3.91 |
| Company | Last | Change |
|---|---|---|
| Alcobra Ltd | 7.40 | -1.99% |
| Charles River Laboratories International Inc | 44.33 | +0.70% |
| Mannkind Corp | 6.75 | +8.35% |
| Alnylam Pharmaceuticals Inc | 27.92 | +0.27% |
| Arena Pharmaceuticals Inc | 8.04 | +1.52% |
Data is delayed by at least 15 min.